Form 4 for IMNM Immunome Inc.
Accepted 2025-03-25 00:00:00 ET · period of report 2025-03-24 · accession 0001415889-25-008920 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-25 | 2025-03-24 | IMNM | BIENAIME JEAN JACQUES | Dir | P - Purchase | $8.21 | +7,000 | 23.6K | +42% | +$57.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-24 | P | A | 7,000 | $8.21 | 23,615 | D | — | — | (F1) The weighted average purchase price for the transaction report was $8.21, and the range of prices were between $8.16 and $8.42, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. |